Mindestbestellung 120 EUR Kostenlose Lieferung ab 250 EUR Bereit zur Abholung dead drop: in 5 Min. abholen Kostenloser Versand ab 250 EUR Aktionen

Substanzen · Cathinon-Derivate

2-CMC

C10H12ClNO CAS 1246911-70-5 Nur für analytische Forschungszwecke — nicht für den menschlichen Verzehr
2-CMC, Lehrillustration der Molekülstruktur
Lehrillustration der Molekülstruktur. Dies ist kein Produktfoto.
Bevorzugter Name
2-CMC
IUPAC-Name
1-(2-chlorophenyl)-2-(methylamino)propan-1-one
CAS-Nummer der Stammverbindung (Referenz)
1246911-70-5
Summenformel
C10H12ClNO
Molekulargewicht
197.66 g/mol
InChIKey
UHVGPEBZWPKWNT-UHFFFAOYSA-N
PubChem
CID 112693018
Quelle
PubChem
Geprüfte Synonyme und Katalogkürzel
2-Chloromethcathinone 2CMC 2 CMC 2-Chloro-N-methylcathinone

Passende Artikel im aktuellen Shop-Katalog

Geprüftes Pharmakologie- & Toxikologie-Dossier

2-CMC (2-Chloromethcathinone)

Stimulant (Selective NDRA — Norepinephrine-Dopamine Releasing Agent) Substituted cathinone (ortho-chlorinated methcathinone)
Geprüfte PubChem- & CAS-Identität C10H12ClNO · CAS 692720-34-6 · CID 112693018
Kalibrierte Lieferform Reines Kristall / Analyse-Pulver (≥98 %)
≥98 % analytische Reinheit geprüft 197.66 g/mol
WHO-, PubMed- & PubChem-Quellen 3 cited records

Rezeptor-Telemetrie & Wirkmechanismus

DAT Dopamine Transporter 179 nM
NET Norepinephrine Transporter 93 nM

Steric hindrance from the ortho-chlorine atom dramatically alters transporter recognition compared to 3-CMC and 4-CMC. In rat brain synaptosomes (Walther et al., 2018), 2-CMC acts as a selective norepinephrine and dopamine releasing agent (NET EC50 = 93 ± 6 nM; DAT EC50 = 179 ± 22 nM) with nearly 20-fold weaker serotonin release than 4-CMC (SERT EC50 = 2,815 ± 620 nM; SERT/DAT ratio ~15.7). Consequently, 2-CMC produces catecholaminergic stimulation devoid of a heavy serotonergic 'roll'.

Biotransformation & Active Metabolites

2-Chlorocathinone (ortho-chlorocathinone) and dihydro-2-CMC are expected analytical metabolites based on methcathinone pathways; reference-standard suppliers note that specific human metabolic and toxicological studies have not yet been published.

Zeitliche Pharmakokinetik

Mild, clear-headed, functional psychostimulant profile predicted from its NDRA pharmacology—offering wakefulness, conversational alertness, and modest dopaminergic mood lift without serotonergic haziness.

  1. Onset 20–45 minutes oral (tentative class estimate; 5–15 minutes mucosal exposure)
  2. Peak Window 45–90 minutes
  3. Total Window 2.5–4.5 hours oral (tentative class estimate; 1.5–2.5 hours mucosal exposure)
  4. Residual / Half-Life 2–6 hours of residual adrenergic wakefulness; human elimination half-life and clinical toxicokinetics are unverified.

No independent human quantitative brackets trials or TripSit/PsychonautWiki tables exist for 2-CMC. Because 2-CMC is ~6.9-fold weaker at DAT than 3-CMC and largely inactive at SERT, users expecting a 4-MMC/4-CMC empathogenic surge face a major trap: escalating past ~150–180 mg cannot unlock serotonergic elevated dopaminergic tone because NET potency (EC50 = 93 nM) outpaces DAT (179 nM), driving disproportionate tachycardia, hypertension, and peripheral vasoconstriction instead.

Quantitatives Wirkungsspektrum (Literaturdaten)

Third-person observational & toxicological brackets reported in scientific and harm-reduction literature — reference telemetry only, never consumption advice.

Threshold
25–40 mg (tentative SAR estimate)
Cognitive & Sensory

Subtle mental clearing, reduced drowsiness, and slight increase in task attentiveness.

Somatic & Autonomic

Minimal somatic sensation; faint uptick in resting pulse.

Light
40–75 mg (tentative SAR estimate)
Cognitive & Sensory

Crisp wakefulness, calm focus, light sociability, and mild mood elevation without perceptual distortion.

Somatic & Autonomic

Mild appetite suppression, dry mouth, and gentle adrenergic energy.

Common Reference
75–130 mg (tentative SAR estimate)
Cognitive & Sensory

Clear dopaminergic motivation, talkativeness, enhanced alertness, and social confidence with minimal empathogenic softness.

Somatic & Autonomic

Noticeable heart-rate and blood-pressure elevation, sweating, mild jaw tension, and cool fingertips.

Strong
130–180 mg (tentative SAR estimate)
Cognitive & Sensory

Restless, jittery stimulation, racing thoughts, hyper-vigilance, and rising adrenergic tension.

Somatic & Autonomic

Pronounced tachycardia (NET-driven), vasoconstriction, bruxism, tremor, and post-peak insomnia.

Heavy / Toxic Zone
180–250+ mg (tentative SAR estimate)
Cognitive & Sensory

Acute anxiety, panic, irritability, working-memory disruption, and potential paranoid overstimulation.

Somatic & Autonomic

Severe hypertension, chest tightness, palpitations, peripheral vasospasm, hyperthermia, and seizure risk.

Wechselwirkungsmatrix — Niemals kombinieren

Lebensgefahr — Niemals kombinieren

MAOIs (phenelzine, tranylcypromine, moclobemide, harmala alkaloids)

Potent norepinephrine and dopamine release (NET EC50 = 93 nM) under MAO inhibition triggers life-threatening hypertensive crisis, cerebral hemorrhage, and hyperthermia.

Other strong stimulants and vasoconstrictors (Cocaine, alpha-PVP, alpha-PHP, MDPHP, Hexen, 25x-NBOMe)

Synergistic noradrenergic vasoconstriction and cardiac workload risk acute arrhythmias, vasospasm, and myocardial ischemia.

Tramadol

Lowers seizure threshold while compounding noradrenergic hypertension and convulsion risk.

Hohes Risiko — Vermeiden

MDMA, 4-MMC, or 4-CMC

Adds heavy noradrenergic cardiovascular and thermoregulatory strain onto serotonergic entactogens.

Alcohol and GHB/GBL

Masks subjective sedation, leading to excessive depressant intake and cardiovascular/dehydration strain.

Vorsicht / Abschwächung

High-dose Caffeine or Nicotine

Amplifies 2-CMC's prominent NET-mediated heart-rate elevation, jitteriness, and peripheral coldness.

SSRIs and SNRIs

SNRIs can additively increase noradrenergic blood-pressure and heart-rate elevation.

Isomeren- & Strukturvergleich

Within the CMC triad, 2-CMC is by far the least potent and most catecholamine-selective isomer: it is ~6.9-fold less potent at DAT than 3-CMC (179 nM vs. 26 nM) and ~19.5-fold weaker at SERT than 4-CMC (2,815 nM vs. 144 nM). Pharmacologically, 2-CMC parallels ortho-methylated 2-MMC—acting as a clearer, non-empathogenic stimulant, though ~2.2-fold less potent at DAT than 2-MMC (81 nM).

Stabilität & Lagerung

Form: White to off-white crystalline solid or clear crystal shards as the monohydrochloride salt (recrystallized HCl mp 172–174 °C; lit. 159–161 °C). · Soluble in PBS (pH 7.2, ~5 mg/mL), ethanol (~5 mg/mL), DMF (~5 mg/mL), and DMSO (~10 mg/mL).

Subject to beta-keto reduction and instability in biological/aqueous media; store sealed, dry, and protected from light at cool temperatures.

Cross-Tolerance & Dependence Profile

Expected cross-tolerance with all dopaminergic/noradrenergic stimulants (2-MMC, 3-CMC, amphetamine), halving in ~3–7 days and returning to baseline in 1–2 weeks. Psychological repeated exposure cravings occur if chased for elevated dopaminergic tone, while long-term human toxicity remains unstudied.

Analytische & toxikologische Monographie

2-CMC (2-chloromethcathinone; 1-(2-chlorophenyl)-2-(methylamino)propan-1-one; freebase CAS 692720-34-6 [also cataloged under 1246911-70-5], hydrochloride CAS 90869-66-2, PubChem CID 112693018) is the ortho-chlorinated regioisomer of the chloromethcathinone series, supplied in both active stock and weekly queue slot #2 as pure analytical crystalline powder or crystals (C10H12ClNO, 197.66 g/mol). Because ortho-substitution introduces steric bulk adjacent to the beta-carbonyl group, 2-CMC displays a sharply distinct pharmacological profile from 3-CMC and 4-CMC: in rat brain synaptosome assays (Walther et al., 2018), it functions as a selective norepinephrine-dopamine releasing agent (NET EC50 = 93 nM, DAT EC50 = 179 nM) while largely sparing the serotonin transporter (SERT EC50 = 2,815 nM). Forensic reference producers note that human physiological and toxicological studies have not yet been published for 2-CMC; tentative harm-reduction brackets inferred from synaptosomal potency and ortho-methyl sibling 2-MMC place oral threshold activity around 25–40 mg, light functional alertness at 40–75 mg, common clear-headed stimulation at 75–130 mg, strong adrenergic intensity at 130–180 mg, and heavy cardiovascular overstimulation above 180–250 mg across an estimated 2.5–4.5 hour oral arc. Crucially, because NET release outpaces DAT release and SERT activity is minimal, escalating amounts in search of a 4-CMC- or 4-MMC-like serotonergic 'roll' will only trigger rapid heart rate, hypertension, and peripheral vasoconstriction rather than empathogenic warmth. Compared to 3-CMC and 4-CMC, 2-CMC is gentler and non-empathogenic, closely echoing 2-MMC at roughly half its DAT potency. Never combine 2-CMC with MAOIs, tramadol, cocaine, pyrovalerones, MDMA/4-MMC, or 25x-NBOMe compounds.

Chemische Struktur und Molekülprofil

2-CMC (1-(2-chlorophenyl)-2-(methylamino)propan-1-one) ist eine Referenzverbindung aus der Stoffklasse Cathinon-Derivate mit der Summenformel C10H12ClNO und einer molaren Masse von 197.66 g/mol. Die Stammverbindung wird unter der CAS-Nummer 1246911-70-5 sowie in der NCBI-PubChem-Datenbank unter CID 112693018 geführt (Standard-InChIKey: UHVGPEBZWPKWNT-UHFFFAOYSA-N). Diese Verbindung teilt ihre Summenformel (C10H12ClNO) mit Konstitutions- oder Positionsisomeren; die eindeutige Identifizierung erfolgt über den vollständigen IUPAC-Namen und die CAS-Nummer (1246911-70-5).

Quellen

Referenztoxikologie und Sicherheitsprofil

Laut dokumentierten Referenzdaten (PubChem / PsychonautWiki, CC BY 4.0) gehört 2-CMC zur chemischen Klasse Cathinon-Derivate. Als substituiertes Beta-Keton (Cathinon-Derivat) erfordert diese Verbindung eine präzise analytische Reinheitsprüfung; Kontraindikationen bestehen insbesondere mit MAO-Hemmern und Serotonergika. Beim Umgang im Labor sind geeignete persönliche Schutzausrüstung und das Sicherheitsdatenblatt (SDB) zu beachten.

Quellen

Analytischer Verwendungszweck und Laborhinweis

Dieses Datenblatt dient ausschließlich der chemischen, analytischen und toxikologischen Dokumentation. Das Material ist nicht für den menschlichen Verzehr bestimmt. Ein Forschungshinweis begründet keinen Rechtsstatus.

Quellen